A Randomized, Non-Inferiority Study Comparing Efficacy and Safety of a Single Dose of Pegfilgrastim versus Daily Filgrastim in Pediatric Patients after Autologous Peripheral Blood Stem Cell Transplant-Reference-Cited by-同舟云学术

A Randomized, Non-Inferiority Study Comparing Efficacy and Safety of a Single Dose of Pegfilgrastim versus Daily Filgrastim in Pediatric Patients after Autologous Peripheral Blood Stem Cell Transplant

Published:2013-01-07 Issue:1 Volume:8 Page:e53252
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Cesaro Simone,Nesi Francesca,Tridello Gloria,Abate Massimo,Panizzolo Irene Sara,Balter Rita,Calore Elisabetta

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. The EBMT activity survey: 1990–2010;JR Passweg;Bone Marrow Transplant,2012

2. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours;MS Aapro;Eur J Cancer,2011

3. Optimal use of G-CSF administration after hematopoietic SCT;M Trivedi;Bone Marrow Transplant,2009

4. Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim;P Samaras;Ann Hematol,2011

5. Pegfilgrastim vs. filgrastim for supportive care after autologous stem cell transplantation: can we decide;PD Ziakas;Clin Transplant,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022;International Journal of Clinical Oncology;2024-04-23

2. Evaluation of a Quality Improvement Process for Health-System Retention of Long Acting Growth Factors Prescriptions in the Pediatric Oncology Population;The Journal of Pediatric Pharmacology and Therapeutics;2024-04-01

3. Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: A systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF 2022;2024-01-12

4. Prevention and Treatment of Oral Mucositis in Pediatric Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials;In Vivo;2024

5. A multicenter phase II trial of primary prophylactic PEG‐rhG‐CSF in pediatric patients with solid tumors and non‐Hodgkin lymphoma after chemotherapy: An interim analysis;Cancer Medicine;2023-05-15